Premier Biomedical Cancer Immunotherapy Research Highlights To Be Presented At AACR Conference

EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical, Inc. (OTCQB: BIEI) announced additional details regarding the presentation of the stunning results of their cancer immunotherapy research, along with additional research results by their UTEP scientist partners, at the upcoming American Association for Cancer Research (AACR) conference, April 16-20, 2016, in New Orleans. The presentation abstract can be found here.